Skip to main content

Cardinal Capital Management

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1434845 RALEIGH, NC

Position in REGN

as of Jun 30, 2026 · filed Jul 21, 2026
Position Value
$5,235,865
-$1,282,126 QoQ
Shares Held
8,397
-0.5% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.64%
of 13F equity value
Holder Rank
#383
of 1,321 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Cardinal Capital Management holds $11,015,873 across 3 Biotechnology names. REGN ranks #1 (47.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
This page
8,397 $5,235,865

All Filings in REGN

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,235,865 8,397
2026-03-31 $6,517,991 8,436
2025-12-31 $6,488,339 8,406
2025-09-30 $4,740,498 8,431
2025-06-30 $4,365,900 8,316
2025-03-31 $5,096,672 8,036
2024-12-31 $5,606,749 7,871
2024-09-30 $8,236,465 7,835
2024-06-30 $8,187,523 7,790
2023-03-31 $6,048,312 7,361
2022-12-31 $5,350,569 7,416
2022-09-30 $5,140,347 7,462
2022-06-30 $4,370,815 7,394
2022-03-31 $5,143,164 7,364
2021-12-31 $4,568,415 7,234
2021-09-30 $4,391,186 7,256
2021-06-30 $4,099,125 7,339
2021-03-31 $3,484,202 7,364
2020-12-31 $3,511,243 7,268
2020-09-30 $4,031,535 7,202
2020-06-30 $4,495,892 7,209
2020-03-31 $3,534,243 7,238